Interleukin-1-mediated febrile responses in mice and interleukin-1 beta activation of NFκB in mouse primary astrocytes, involves the interleukin-1 receptor accessory protein

European Cytokine Network

Volumn 9, Issue 2, 1998, Pages 131-138

  Zetterström, Maria ^a   Lundkvist, Johan ^a   Malinowsky, David ^a   Eriksson, Gun ^a   Bartfai, Tamas ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

CNS; Fever; IL 1 receptor accessory protein; Interleukin 1; NF B

Indexed keywords

ESCHERICHIA COLI LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ASTROCYTE; FEVER; MOUSE; NONHUMAN;

ANIMALS; ASTROCYTES; BIOLOGICAL TRANSPORT; CELL NUCLEUS; CELLS, CULTURED; FEVER; HUMANS; INTERLEUKIN-1; INTERLEUKIN-1 RECEPTOR ACCESSORY PROTEIN; MICE; MICE, MUTANT STRAINS; NF-KAPPA B; PROTEINS; RATS; RECEPTORS, INTERLEUKIN-1; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION;

ANIMALIA; ESCHERICHIA COLI;

EID: 0031810606     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Dinarello C A. 1996. Biological basis for interleukin-1 in disease. (Review) Blood 87: 2095.
2. Auron P E, Webb A C, Rosenwasser L J, Mucci S F, Rich A, Wolff S M, Dinarello C A. 1984. Nucleotide sequence of human monocyte interleukin-1 precursor cDNA. Proc. Natl. Acad. Sci. USA. 81: 7907.
3. March C J, Mosley B, Larsen A, Cerretti D P, Braedt G, Price V, Gillis S, Henney C S, Kronheim S R, Grabstein K, Conlon P J, Hopp T P, Cosman D. 1985. Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs. Nature 315: 641.
4. Eisenberg S P, Evans R J, Arend W, Verderber E, Brewer M T, Hannum C H, Thompson R C. 1990. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 343: 341.
5. Howard A D, Kostura M J, Thornberry N, Ding G J, Limjuco G, Weidner J, Salley J P, Hogquist K A, Chaplin D D, Mumford R A, Schmidt J A, Tocci M J. 1991. IL-1-converting enzyme requires aspartic acid residues for processing of the IL-1beta precursor at two distinct sites and does not cleave 31-kDa IL-1alpha. J. Immunol. 147: 2964.
6. Haskill S, Martin G, Van Le L, Morris J, Peace A, Bigler C F, Jaffe G J, Hammerberg C, Sporn S A, Fong S, Arend W P, Ralph P. 1991. cDNA cloning of an intracellular form of the human interleukin-1 receptor antagonist associated with epithelium. Proc Natl. Acad. Sci. USA. 88: 3681.
7. Muzio M, Polentarutti N, Sironi M, Poli G, De Gioia L, Introna M, Mantovani A, Colotta F. 1995. Cloning and characterization of a new isoform of the interleukin-1 receptor antagonist. J. Exp. Med. 182: 623.
8. Watson J M, Lofquist A K, Rinehart C A, Olsen J C, Makarov S S, Kaufman D G, Haskill J S. 1995. The intracellular IL-1 receptor antagonist alters IL-1-inducible gene expression without blocking exogenous signaling by IL-1β. J. Immunol. 155: 4467.
9. Sims J E, March C J, Cosman D, Widmer M, MacDonald B, McMahan C J, Grubin C E, Wignall J M, Jackson J L, Call S M, Friend D, Alpert N, Gillis S, Urdal DL, Dower S K. 1988. cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science 241: 585.
10. McMahan C J, Slack J L, Mosley B, Cosman D, Lupton S D, Brunton L L, Grubing C E, Wignall J M, Jenkins N A, Brannan C T, Copeland N, Huebner K, Croce C, Canizzarro L, Benjamin D, Dower S, Spriggs M, Sims J E. 1991. A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J. 10: 2821.
11. Sims J E, Gayle M A, Slack J L, Alderson M R, Bird T A, Giri J G, Colotta F, Re F, Mantovani A, Shanebeck K, Grabstein K H, Dower S K. 1993. Interleukin-1 signaling occurs exclusively via the type 1 receptor. Proc. Natl. Acad. Sci. USA. 90: 6155.
12. Malinowsky D, Chai Z, Bristulf J, Simoncsits A, Bartfai T. 1995. The type I interleukin-1 receptor mediates fever in the rat as shown by interleukin-1 receptor subtype selective ligands. Neurosci. Lett. 201: 33.
13. Labow M, Shuster D, Zetterström M, Nunes P, Terry R, Cullinan E, Bartfai T, Solorzano C, Moldawer L L, Chizzonite R, McIntyre K W. 1997. Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice. J. Immunol. 159: 2452.
14. Sims J E, Dower S K. 1994. Interleukin-1 receptors. (Review) Eur. Cytokine Netw. 5: 539.
15. Colotta F, Re F, Muzio M, Bertini R, Polentarutti N, Sironi M, Giri J G, Dower S K, Sims J E, Mantovani A. 1993. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 261: 472.
16. Greenfeder S A, Nunes P, Kwee L, Labow M, Chizzonite R, Ju G. 1995. Molecular cloning and characterization of a second subunit of the interleukin-1 receptor complex. J. Biol. Chem. 270: 13757.
17. Korherr C, Hofmeister R, Wesche H, Falk W. 1997. A critical role for interleukin-1 receptor accessory protein in interleukin-1 signaling. Eur. J. Immunol. 27: 262.
18. Wesche H, Korherr C, Kracht M, Falk W, Resch K, Martin M U. 1997. The interleukin-1 receptor accessory protein (IL-1RAcP) is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases). J. Biol. Chem. 272: 7727.
19. Martin M U, Falk W. 1997. The interleukin-1 receptor complex and interleukin-1 signal transduction. (Review) Eur. Cytokine Netw. 8: 5.
20. Hofmeister R, Wiegmann K, Korherr C, Bernardo K, Kronke M, Falk W. 1997. Activation of acid sphingomyelinase by interleukin-1 (IL-1) requires the IL-1 receptor accessory protein. J. Biol. Chem. 272: 27730.
21. Kluger M J. 1991. Fever: role of pyrogens and cryogens. (Review) Physiol Rev. 71: 93.
22. Dantzer R, Bluthé R M, Kent S, Kelley K V. 1991. Behavioural effects of cytokines In: Rothwell N and Dantzer R. Eds. Interleukin-1 in the brain. Pergamon Press. 135.
23. Giulian D, Woodward J, Young D G, Krebs J F, Lachman L B. 1988. Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization. J. Neurosci. 8: 2485.
24. Merrill J E. 1991. Effects of interleukin-1 and tumor necrosis factor-alpha on astrocytes, microglia, oligodendrocytes, and glial precursors in vitro. Dev. Neuroscience 13: 130.
25. Frei K, Bodmer S, Schwerdel C, Fontana A. 1985. Astrocytes of the brain synthesize interleukin-3-like factors. J. Immunol. 135: 4044.
26. Merrill J E. 1992. Proinflammatory and anti-inflammatory cytokines in multiple sclerosis and central nervous system acquired immunodeficiency syndrome. (Review) J. Immunother. 12: 167.
27. Benveniste E N. 1992. Inflammatory cytokines within the central nervous system: sources, function and mechanism of action. Am. J. Physiol. 263: C1.
28. Liu C, Chalmers D, Maki R, De Souza E B. 1996. Rat homolog of mouse interleukin-1 receptor accessory protein, cloning, localization and modulation studies. J. Neuroimmunol. 66: 41.
29. Baeuerle P A, Henkel T. 1995. Function and activation of NFκB in the immune system. (Review) Ann. Rev. Immunol. 12: 141.
30. Baeuerle P A, Baltimore D. 1991. The physiology of the NFκB transcription factor. In : Cohen Pea. Eds. Molecular aspects of cellular regulation-hormonal control of gene transcription. North Holland: Elsevier, 409.
31. Baeuerle P A. 1991. The inducible transcription activator NFκB: regulation by distinct protein subunits. (Review) Biochim. Biophys. Acta 1072: 63.
32. Sparacio S M, Zhang Y, Vilcek J, Benveniste E N. 1992. Cytokine regulation of interleukin-6 gene expression in astrocytes involves activation of an NFκB-like nuclear protein. J. Neuroimmunol. 39:231.
33. Simoncsits A, Bristulf J, Tjornhammar M L, Cserao M, Pongor S, Rybakina E, Gatti S, Bartfai T. 1994. Deletion mutants of human interleukin-1β with significantly reduced agonist properties: search for the agonist/antagonist switch in ligands to the interleukin-1 receptors. Cytokine 6: 206.
34. Bradford M M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248.
35. Eriksson G, Zetterström M, Cortes Toro V, Bartfai T, Iverfeldt K. 1998. Hypersensitive cytokine responses in astrocytes from IL-1 receptor type I deficient mice to β amyloid 25-35. Int. J. Mol. Med. 1: 201.
36. Schreiber E, Matthias P, Muller M M, Schaffner W. 1989. Rapid detection of octamer binding proteins with "mini-extracts", prepared from a small number of cells. Nucleic Acids Res. 17: 6419.
37. Dascombe M J, Rothwell N J, Sagay B O, Stock M J. 1989. Pyrogenic and thermogenic effects of interleukin-1β in the rat. Am. J. Physiol. 256: E7.
38. Alheim K, Chai Z, Fantuzzi G, Hasanvan H, Malinowsky D, Di Santo E, Ghezzi P, Dinarello C, Bartfai T. 1997. Hyperresponsive febrile reactions to interleukin-(IL) 1alpha and IL-1beta, and altered brain cytokine mRNA and serum cytokine levels, in IL-1beta-deficient mice. Proc. Natl. Acad. Sci. USA. 94: 2681.
39. Luheshi G, Miller A J, Brouwer S, Dascombe M J, Rothwell N J, Hopkins S J. 1996. Interleukin-1 receptor antagonist inhibits endotoxin fever and systemic interleukin-6 induction in the rat. Am. J. Physiol. 270: E91.
40. Long N C, Otterness I, Kunkel S L, Vander A J, Kluger M J. 1990. Roles of interleukin-1beta and tumor necrosis factor in lipopolysaccharide fever in rats. Am. J. Physiol. 259: R724.
41. Leon L R, Conn C A, Glaccum M, Kluger M J. 1996. IL-1 type I receptor mediates acute phase response to turpentine, but not lipopolysaccharide, in mice. Am. J. Physiol. 271: R1668.
42. Griffin W S, Stanley L C, Ling C, White L, MacLeod V, Perrot L J, White C 3d, Araoz C. 1989. Brain interleukin-1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. USA 86: 7611.
43. Rossi B. 1993. IL-1 transduction signals. (Review) Eur. Cytokine Netw. 4: 181.